Lynnette C.  Fallon net worth and biography

Lynnette Fallon Biography and Net Worth

Director of ClearPoint Neuro

Lynnette C. Fallon joined our Board in July 2021. Ms. Fallon is currently a Senior Advisor at Axcelis Technologies, Inc. (Nasdaq: ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon served as Axcelis’ Executive Vice President, HR/Legal from May 2005 until February 2025, also holding the roles of General Counsel and Secretary from 2001 until December 2024. As a member of Axcelis’ executive team for more than 20 years, Ms. Fallon was involved with business development, financial and tax management, investor relations, public offerings, M&A, risk management, executive compensation, and all aspects of international corporate compliance. Before joining Axcelis, Ms. Fallon worked at the Boston law firm of Palmer & Dodge LLP as a partner from 1992 to 2001, prior to which she was an associate since 1987. During her more than 10 years at Palmer & Dodge, Ms. Fallon’s work was primarily for clients in the biotech industry. She was head of Palmer & Dodge’s business law department for the three years prior to joining Axcelis. Ms. Fallon’s M&A and financial transaction experience began in 1984 at a Wall Street boutique firm, doing tax-driven LBOs, venture capital and private equity transactions. She holds a J.D., cum laude, from the School of Law at Boston University and a B.A. with departmental and general honors, Phi Beta Kappa, from Vassar College. We believe that Ms. Fallon is qualified to serve on our Board given her extensive business and leadership experience and her legal expertise.

What is Lynnette C. Fallon's net worth?

The estimated net worth of Lynnette C. Fallon is at least $639.92 thousand as of May 20th, 2026. Fallon owns 48,227 shares of ClearPoint Neuro stock worth more than $639,924 as of June 12th. This net worth evaluation does not reflect any other assets that Fallon may own. Learn More about Lynnette C. Fallon's net worth.

How do I contact Lynnette C. Fallon?

The corporate mailing address for Fallon and other ClearPoint Neuro executives is 5 MUSICK, IRVINE CA, 92618. ClearPoint Neuro can also be reached via phone at (949) 900-6833 and via email at [email protected]. Learn More on Lynnette C. Fallon's contact information.

Has Lynnette C. Fallon been buying or selling shares of ClearPoint Neuro?

Over the course of the past ninety days, Lynnette C. Fallon has sold $56,713.74 of ClearPoint Neuro stock. Most recently, Lynnette C. Fallon sold 5,091 shares of the business's stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $11.14, for a transaction totalling $56,713.74. Following the completion of the sale, the director now directly owns 48,227 shares of the company's stock, valued at $537,248.78. Learn More on Lynnette C. Fallon's trading history.

Who are ClearPoint Neuro's active insiders?

ClearPoint Neuro's insider roster includes Joseph Burnett (CEO), Joseph Burnett (President & CEO), Lynnette Fallon (Director), and Timothy Richards (Director). Learn More on ClearPoint Neuro's active insiders.

Are insiders buying or selling shares of ClearPoint Neuro?

During the last year, insiders at the sold shares 6 times. They sold a total of 75,912 shares worth more than $1,390,248.54. The most recent insider tranaction occured on June, 1st when Director Timothy T Richards sold 5,415 shares worth more than $65,900.55. Insiders at ClearPoint Neuro own 6.9% of the company. Learn More about insider trades at ClearPoint Neuro.

Information on this page was last updated on 6/1/2026.

Lynnette C. Fallon Insider Trading History at ClearPoint Neuro

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2026Sell5,091$11.14$56,713.7448,227View SEC Filing Icon  
See Full Table

Lynnette C. Fallon Buying and Selling Activity at ClearPoint Neuro

This chart shows Lynnette C Fallon's buying and selling at ClearPoint Neuro by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ClearPoint Neuro Company Overview

ClearPoint Neuro logo
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Read More

Today's Range

Now: $13.44
Low: $13.07
High: $14.12

50 Day Range

MA: $11.41
Low: $8.68
High: $14.32

2 Week Range

Now: $13.44
Low: $8.27
High: $30.10

Volume

447,044 shs

Average Volume

702,594 shs

Market Capitalization

$403.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31